A-TANGO Overview
- Headquarters
- Es
- Website
- atango.eu
- Industry
- Research
- Employees
- 2
- Founded
- 2021
About A-TANGO
About 30,000 Europeans die every year from alcohol-related cirrhosis. In its final stages, the disease leads to acute-on-chronic liver failure (ACLF), a syndrome characterised by multi-organ failure. Effective treatment of ACLF is an urgent and unmet need. The A-TANGO consortium performs Phase II clinical studies of an innovative therapeutic strategy that targets inflammation and improves hepatocyte proliferation. We call this novel combinatorial therapy “G-TAK”. In addition, A-TANGO strives to identify reliable biomarkers for better patient stratification and an increased survival rate.
A-TANGO Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
A-TANGO Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Nina Donner (Phd) | Empowering European Science | Fürstenfeldbruck, Bavaria, Germany |
Email
|
Compare Similar Companies to A-TANGO
DKMS Stem Cell Bank
Non-Profit Organizations
European Liver Patients' Association - ELPA
Civic And Social Organizations
European Foundation for the Study of Chronic Liver Failure (EF CLIF)
Research Services
NEWDOOR
Civic And Social Organizations
Royan Education
Education Management
MICROB-PREDICT
Research
Criteria Bio Ventures
Venture Capital And Private Equity Principals
Royan رویان
Information Technology & Services
DECISION-Project
Research Services
International Donor Registry Conference
Hospitals And Health Care